HTG Molecular Diagnostics reported after the close of the market on Tuesday that its 2021 revenues edged up 5 percent to $8.9 million from $8.5 million a year ago.

Cue Health on Tuesday afternoon announced a whopping year-over-year uptick in revenues for the fourth quarter, beating the consensus Wall Street estimate.

On March 30, Rendu Biotechnology was listed on SSE Star Market, stock code: 688193. The issue price is 72.65 per share, and a total of 136,100 shares were issued.

On March 9, Autobio released a performance report. The company's sales revenue from January to December 2021 was CNY 3.767 billion , a year-on-year increase of 26.48%.

The updated prospectus shows that Adicon additionally disclosed financial data for 2021 and other content. According to the prospectus, Adicon's operating income in 2021 will be CNY 3.380 billion.

On March 2, the FTSE Russell Day announced the results of the quarterly audit changes of the FTSE China A50 and other indices.

Agilent Technologies reported after the close of the market on Tuesday that its fiscal first quarter revenues rose 8 percent year over year.

Roche on Thursday reported a 29 percent year-over-year increase in sales in its diagnostics division for full-year 2021, driven by momentum in the base business and continued demand for COVID-19 testing.

On January 29, Shenzhen Tisenc Medical Devices Co., Ltd. underwent an industrial and commercial change. All the original shareholders withdrew, and WONDFO BIOTECH (300482) was newly added, holding 100% of the shares.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta Corp.